Urothelial carcinoma of the upper urinary tract diagnosed via FGFR3 mutation detection in urine: a case report
BMC Urology, 08/09/2012
Silverberg D – This study indicates that the FGFR3 urine assay, which was originally developed to monitor bladder cancer, is also a useful tool for diagnosing upper urinary tract cancer in a real–life setting.



